US Patent 11344610 Prevention and reduction of blood loss
Patent 11344610 was granted and assigned to Takeda Pharmaceutical Company on May, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Anthony Williams0
Arthur Charles Ley0
Robert Charles Ladner0
Shirish Hirani0
Edits on 24 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 21 Apr, 2023
Golden AI
Infobox
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113446100
Date of Patent
May 31, 2022
0Patent Application Number
162812760
Date Filed
February 21, 2019
0Patent Citations
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 1 Jun, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+398 characters)
US Patent 11344610 Prevention and reduction of blood loss
Article
Methods are described for preventing or reducing ischemia and/or systemic inflammatory response in a patient such as perioperative blood loss and/or systemic inflammatory response in a patient subjected to cardiothoracic surgery, e.g. coronary artery bypass grafting and other surgical procedures, especially when such procedures involve extra-corporeal circulation, such as cardiopulmonary bypass.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11344610
Date of patent
May 31, 2022
Patent application number
16281276
Date Filed
February 21, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 11344610 Prevention and reduction of blood loss
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
